Stocks to Buy based on the Best Stock Market Research
Today is the first day of stock trading in 2017 and we already have a red hot stock. Check out Interpace Diagnostics Group, Inc. (IDXG) which is topping the list of biggest stock gainers, up 79% to $7.90. IDXG exploded from $4.90 to over $8 in the first 30 minutes of trading today and it keeps going. Watch this hot stock in 2017!
Interpace Diagnostics Corp. (IDXG), a company that provides clinically useful molecular diagnostic tests and pathology services for evaluating risks of cancer, announced today that the Company has entered in to an Agreement with the Blue Cross Blue Shield (BCBS) Association's Center for Clinical Effectiveness "Evidence Street", a program that, while not making coverage decisions, provides the Company with the opportunity to provide available evidence for its molecular Thyroid and Pancreas tests, to support further coverage determinations among Blue Cross Blue Shield and other health plans. Blue Cross Blue Shield's 36 independent plans and Companies account for approximately 106 million covered lives in the U.S.